Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia

Neuroscience Research

Volumn 55, Issue 3, 2006, Pages 334-341

  Forero, Diego A ^a   Benítez, Bruno ^a   Arboleda, Gonzalo ^a,b   Yunis, Juan J ^a,b   Pardo, Rodrigo ^a,b   Arboleda, Humberto ^a,b  

^a Instituto de Genética Servicios Médicos Yunis Turbay y Cia   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Alzheimer's disease; Colombia; Genetic association; Genetic polymorphisms; Synaptic plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; UBIQUITIN THIOLESTERASE;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; COLOMBIA; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE;

AGED; ALZHEIMER DISEASE; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; COHORT STUDIES; COLOMBIA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE REGENERATION; NEURONAL PLASTICITY; POLYMORPHISM, GENETIC; RECOVERY OF FUNCTION; UBIQUITIN THIOLESTERASE;

EID: 33646800203     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.04.006     Document Type: Article

References (80)

1. Altar C.A., Jurata L.W., Charles V., Lemire A., Liu P., Bukhman Y., Young T.A., Bullard J., Yokoe H., Webster M.J., Knable M.B., and Brockman J.A. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol. Psychiatry 58 (2005) 85-96
2. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., and Donnelly P. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
3. Arboleda G.H., Yunis J.J., Pardo R., Gomez C.M., Hedmont D., Arango G., and Arboleda H. Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer's disease. Neurosci. Lett. 305 (2001) 135-138
4. Arendt T. Neurodegeneration and plasticity. Int. J. Dev. Neurosci. 22 (2004) 507-514
5. Bagnoli S., Nacmias B., Tedde A., Guarnieri B.M., Cellini E., Petruzzi C., Bartoli A., Ortenzi L., and Sorbi S. Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann. Neurol. 55 (2004) 447-448
6. Bertram L., and Tanzi R.E. Alzheimer's disease: one disorder, too many genes?. Hum. Mol. Genet. 13 Spec No. 1 (2004) R135-R141
7. Beskow L.M., Burke W., Merz J.F., Barr P.A., Terry S., Penchaszadeh V.B., Gostin L.O., Gwinn M., and Khoury M.J. Informed consent for population-based research involving genetics. JAMA 286 (2001) 2315-2321
8. Bian J.T., Zhang J.W., Zhang Z.X., and Zhao H.L. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese. Neurosci. Lett. 387 (2005) 11-16
9. Bingol B., and Schuman E.M. Synaptic protein degradation by the ubiquitin proteasome system. Curr. Opin. Neurobiol. 15 (2005) 536-541
10. Blasi G., Mattay V.S., Bertolino A., Elvevag B., Callicott J.H., Das S., Kolachana B.S., Egan M.F., Goldberg T.E., and Weinberger D.R. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J. Neurosci. 25 (2005) 5038-5045
11. Bodner S.M., Berrettini W., van Deerlin V., Bennett D.A., Wilson R.S., Trojanowski J.Q., and Arnold S.E. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134 (2005) 1-5
12. Borroni B., Agosti C., Archetti S., Costanzi C., Bonomi S., Ghianda D., Lenzi G.L., Caimi L., Di L.M., and Padovani A. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease. Neurosci. Lett. 370 (2004) 127-129
13. Botstein D., and Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33 Suppl. (2003) 228-237
14. Camelo D., Arboleda G., Yunis J.J., Pardo R., Arango G., Solano E., Lopez L., Hedmont D., and Arboleda H. Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients. J. Neurol. Sci. 218 (2004) 47-51
15. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., and Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33 (2002) 562-571
16. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., and Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279 (2004) 13256-13264
17. Coleman P., Federoff H., and Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63 (2004) 1155-1162
18. Combarros O., Infante J., Llorca J., and Berciano J. Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 18 (2004) 55-58
19. Crawford D.C., Akey D.T., and Nickerson D.A. The patterns of natural variation in human genes. Annu. Rev. Genomics Hum. Genet. 6 (2005) 287-312
20. de Frias C.M., Annerbrink K., Westberg L., Eriksson E., Adolfsson R., and Nilsson L.G. Catechol-O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J. Cogn. Neurosci. 17 (2005) 1018-1025
21. Demyttenaere K., Bruffaerts R., Posada-Villa J., Gasquet I., Kovess V., Lepine J.P., Angermeyer M.C., Bernert S., de G.G., Morosini P., Polidori G., Kikkawa T., Kawakami N., Ono Y., Takeshima T., Uda H., Karam E.G., Fayyad J.A., Karam A.N., Mneimneh Z.N., Medina-Mora M.E., Borges G., Lara C., de G.R., Ormel J., Gureje O., Shen Y., Huang Y., Zhang M., Alonso J., Haro J.M., Vilagut G., Bromet E.J., Gluzman S., Webb C., Kessler R.C., Merikangas K.R., Anthony J.C., Von Korff M.R., Wang P.S., Brugha T.S., guilar-Gaxiola S., Lee S., Heeringa S., Pennell B.E., Zaslavsky A.M., Ustun T.B., and Chatterji S. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291 (2004) 2581-2590
22. Desai P., Nebes R., Dekosky S.T., and Kamboh M.I. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci. Lett. 379 (2005) 229-234
23. DiAntonio A., and Hicke L. Ubiquitin-dependent regulation of the synapse. Annu. Rev. Neurosci. 27 (2004) 223-246
24. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., and Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6917-6922
25. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
26. Forero, D.A., Arboleda, G., Yunis, J.J., Pardo, R., Arboleda, H. Association study of polymorphisms in LRP1, Tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients. J. Neural. Transm., in press, doi:10.1007/s00702-005-0388-z.
27. Gong, B., Cao, Z., Zheng, P., Vitolo, O.V., Liu, S., Staniszewski, A., Shelanski, M., Arancio, O., 2005. Transduction of UCH-L1 protein reverses synaptic and cognitive impairments in a mouse model of Alzheimer's disease. Program No.554.16.2005 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC (Online).
28. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., and Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 114 (2004) 1624-1634
29. Grunblatt E., Mandel S., Jacob-Hirsch J., Zeligson S., Amariglo N., Rechavi G., Li J., Ravid R., Roggendorf W., Riederer P., and Youdim M.B. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J. Neural. Transm. 111 (2004) 1543-1573
30. Harris S.E., Wright A.F., Hayward C., Starr J.M., Whalley L.J., and Deary I.J. The functional COMT polymorphism, Val 158 Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds. Neurosci. Lett. 385 (2005) 1-6
31. Healy D.G., bou-Sleiman P.M., Quinn N., Ahmadi K.R., Ozawa T., Kamm C., Wullner U., Oertel W.H., Burk K., Dupont E., Pellecchia M.T., Tolosa E., Gasser T., Holton J.L., Revesz T., Goldstein D.B., Lees A.J., and Wood N.W. UCHL-1 gene in multiple system atrophy: a haplotype tagging approach. Mov. Disord. 20 (2005) 1338-1343
32. Healy D.G., bou-Sleiman P.M., and Wood N.W. Genetic causes of Parkinson's disease: UCHL-1. Cell Tissue Res. 318 (2004) 189-194
33. Hegde A.N. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog. Neurobiol. 73 (2004) 311-357
34. Hegde A.N., Inokuchi K., Pei W., Casadio A., Ghirardi M., Chain D.G., Martin K.C., Kandel E.R., and Schwartz J.H. Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89 (1997) 115-126
35. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294 (2001) 1030-1038
36. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19 (1991) 5444
37. Lam Y.A., Pickart C.M., Alban A., Landon M., Jamieson C., Ramage R., Mayer R.J., and Layfield R. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9902-9906
38. Lee J., Fukumoto H., Orne J., Klucken J., Raju S., Vanderburg C.R., Irizarry M.C., Hyman B.T., and Ingelsson M. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp. Neurol. 194 (2005) 91-96
39. Leroy E., Boyer R., and Polymeropoulos M.H. Intron-exon structure of ubiquitin c-terminal hydrolase-L1. DNA Res. 5 (1998) 397-400
40. Li Y., Rowland C., Tacey K., Catanese J., Sninsky J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Goate A., Owen M., Williams J., and Grupe A. The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples. Mol. Psychiatry 10 (2005) 809-810
41. Lincoln S., Vaughan J., Wood N., Baker M., Adamson J., Gwinn-Hardy K., Lynch T., Hardy J., and Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport 10 (1999) 427-429
42. Liu Q., Thorland E.C., Heit J.A., and Sommer S.S. Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes. Genome Res. 7 (1997) 389-398
43. Liu Q.R., Walther D., Drgon T., Polesskaya O., Lesnick T.G., Strain K.J., de A.M., Bower J.H., Maraganore D.M., and Uhl G.R. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134 (2005) 93-103
44. Liu Y., Fallon L., Lashuel H.A., Liu Z., and Lansbury Jr. P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111 (2002) 209-218
45. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33 (2003) 177-182
46. Lombardino A.J., Li X.C., Hertel M., and Nottebohm F. Replaceable neurons and neurodegenerative disease share depressed UCHL1 levels. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8036-8041
47. Lu B., and Gottschalk W. Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog. Brain Res. 128 (2000) 231-241
48. Mandel S., Grunblatt E., Riederer P., Amariglio N., Jacob-Hirsch J., Rechavi G., and Youdim M.B. Gene expression profiling of sporadic parkinson's disease substantia Nigra pars compacta reveals impairment of Ubiquitin-Proteasome subunits, SKP1A, aldehyde dehydrogenase, and Chaperone HSC-70. Ann. N.Y. Acad. Sci. 1053 (2005) 356-375
49. Maraganore D.M., Lesnick T.G., Elbaz A., Chartier-Harlin M.C., Gasser T., Kruger R., Hattori N., Mellick G.D., Quattrone A., Satoh J., Toda T., Wang J., Ioannidis J.P., de A.M., and Rocca W.A. UCHL1 is a Parkinson's disease susceptibility gene. Ann. Neurol. 55 (2004) 512-521
50. Matsushita S., Arai H., Matsui T., Yuzuriha T., Urakami K., Masaki T., and Higuchi S. Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J. Neural. Transm. 112 (2005) 703-771
51. Momose Y., Murata M., Kobayashi K., Tachikawa M., Nakabayashi Y., Kanazawa I., and Toda T. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann. Neurol. 51 (2002) 133-136
52. Naze P., Vuillaume I., Destee A., Pasquier F., and Sablonniere B. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neurosci. Lett. 328 (2002) 1-4
53. Nishikawa K., Li H., Kawamura R., Osaka H., Wang Y.L., Hara Y., Hirokawa T., Manago Y., Amano T., Noda M., Aoki S., and Wada K. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 304 (2003) 176-183
54. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., Harada T., Hara Y., Kimura I., Chiba S., Namikawa K., Kiyama H., Noda M., Aoki S., and Wada K. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 12 (2003) 1945-1958
55. Oswald P., Del-Favero J., Massat I., Souery D., Claes S., Van Broeckhoven C., and Mendlewicz J. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129 (2004) 34-35
56. Parra-Bonilla G., Arboleda G., Yunis J., Solano E., Pardo R., Arango G., Hedmont D., and Arboleda H. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients. Neurosci. Lett. 349 (2003) 159-162
57. Pradilla A.G., Vesga A.B., and Leon-Sarmiento F.E. National neuroepidemiological study in Colombia (EPINEURO). Rev. Panam. Salud. Publica. 14 (2003) 104-111
58. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
59. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., and Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 284-289
60. Satoh J.I., and Kuroda Y. Ubiquitin C-terminal hydrolase-L1 (PGP9.5) expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines, neurotrophic factors or heat stress. Neuropathol. Appl. Neurobiol. 27 (2001) 95-104
61. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
62. Shield A.J., Thomae B.A., Eckloff B.W., Wieben E.D., and Weinshilboum R.M. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol. Psychiatry 9 (2004) 151-160
63. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., Craddock N., DePaulo J.R., and Lander E.S. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 7 (2002) 579-593
64. Tsai S.J., Hong C.J., Liu H.C., Liu T.Y., Hsu L.E., and Lin C.H. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 49 (2004) 0-12
65. Tsai S.J., Liao D.L., Yu Y.W., Chen T.J., Wu H.C., Lin C.H., Cheng C.Y., and Hong C.J. A study of the association of (Val66Met) polymorphism in the brain-derived neurotrophic factor gene with alcohol dependence and extreme violence in Chinese males. Neurosci. Lett. 381 (2005) 340-343
66. Tully T., Bourtchouladze R., Scott R., and Tallman J. Targeting the CREB pathway for memory enhancers. Nat. Rev. Drug Discov. 2 (2003) 267-277
67. Uhl G.R., and Grow R.W. The burden of complex genetics in brain disorders. Arch. Gen. Psychiatry 61 (2004) 223-229
68. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., Neubauer A., Sonnemans M.A., Sluijs J.A., Koycu S., Ramdjielal R.D., Salehi A., Martens G.J., Grosveld F.G., Peter J., Burbach H., and Hol E.M. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279 (1998) 242-247
69. Ventriglia M., Bocchio C.L., Benussi L., Binetti G., Zanetti O., Riva M.A., and Gennarelli M. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol. Psychiatry 7 (2002) 136-137
70. Vepsalainen S., Castren E., Helisalmi S., Iivonen S., Mannermaa A., Lehtovirta M., Hanninen T., Soininen H., and Hiltunen M. Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J. Neurol. 252 (2005) 423-428
71. Wang P.N., Liu H.C., Liu T.Y., Chu A., Hong C.J., Lin K.N., and Chi C.W. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease. Dement. Geriatr. Cogn. Disord. 19 (2005) 120-125
72. Warwick D.E., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., and Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66 (2000) 196-204
73. Wilkinson K.D., Lee K.M., Deshpande S., Duerksen-Hughes P., Boss J.M., and Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246 (1989) 670-673
74. Wimo A., Winblad B., Aguero-Torres H., and von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis. Assoc. Disord. 17 (2003) 63-67
75. Wood M.A., Kaplan M.P., Brensinger C.M., Guo W., and Abel T. Ubiquitin C-terminal hydrolase L3 (UCHL3) is involved in working memory. Hippocampus 15 (2005) 610-621
76. Yi J.J., and Ehlers M.D. Ubiquitin and protein turnover in synapse function. Neuron 5 (2005) 629-632
77. Yu H., Saura C.A., Choi S.Y., Sun L.D., Yang X., Handler M., Kawarabayashi T., Younkin L., Fedeles B., Wilson M.A., Younkin S., Kandel E.R., Kirkwood A., and Shen J. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 31 (2001) 713-726
78. Yunis J.J., Garcia O., Cuervo A.G., Guio E., Pineda C.R., and Yunis E.J. Population data for PowerPlex 16 in thirteen departments and the capital city of Colombia. J. Forensic Sci. 50 (2005) 685-702
79. Yunis J.J., Garcia O., Uriarte I., and Yunis E.J. Population data on 6 short tandem repeat loci in a sample of Caucasian-Mestizos from Colombia. Int. J. Legal Med. 113 (2000) 175-178
80. Zubenko G.S., Hughes III H.B., Stiffler J.S., Brechbiel A., Zubenko W.N., Maher B.S., and Marazita M.L. Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol. Psychiatry 8 (2003) 611-618